Cargando…
Liquid Biopsy in Small Cell Lung Cancer—A Route to Improved Clinical Care?
Small cell lung cancer (SCLC) has a particularly poor prognosis despite the high initial response to first-line systemic therapy, and there is a well-recognised lack of meaningful treatments beyond the second line. A number of reasons have been put forward to explain this, including a lack of common...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761700/ https://www.ncbi.nlm.nih.gov/pubmed/33287165 http://dx.doi.org/10.3390/cells9122586 |